171 related articles for article (PubMed ID: 11591143)
1. Apolipoprotein A-II/A-I ratio is a key determinant in vivo of HDL concentration and formation of pre-beta HDL containing apolipoprotein A-II.
Pastier D; Dugué S; Boisfer E; Atger V; Tran NQ; van Tol A; Chapman MJ; Chambaz J; Laplaud PM; Kalopissis AD
Biochemistry; 2001 Oct; 40(41):12243-53. PubMed ID: 11591143
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of gemfibrozil on lipoprotein metabolism.
Saku K; Gartside PS; Hynd BA; Kashyap ML
J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis.
Boisfer E; Lambert G; Atger V; Tran NQ; Pastier D; Benetollo C; Trottier JF; Beaucamps I; Antonucci M; Laplaud M; Griglio S; Chambaz J; Kalopissis AD
J Biol Chem; 1999 Apr; 274(17):11564-72. PubMed ID: 10206963
[TBL] [Abstract][Full Text] [Related]
4. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
[TBL] [Abstract][Full Text] [Related]
5. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
6. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
[TBL] [Abstract][Full Text] [Related]
7. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.
Fan J; Ji ZS; Huang Y; de Silva H; Sanan D; Mahley RW; Innerarity TL; Taylor JM
J Clin Invest; 1998 May; 101(10):2151-64. PubMed ID: 9593771
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II.
Boisfer E; Stengel D; Pastier D; Laplaud PM; Dousset N; Ninio E; Kalopissis AD
J Lipid Res; 2002 May; 43(5):732-41. PubMed ID: 11971944
[TBL] [Abstract][Full Text] [Related]
10. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
[TBL] [Abstract][Full Text] [Related]
11. High levels of human apolipoprotein A-I and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins. Relevance to regression of atherosclerosis?
Stein O; Dabach Y; Hollander G; Ben-Naim M; Halperin G; Stein Y
Atherosclerosis; 1999 Jun; 144(2):367-74. PubMed ID: 10407497
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
13. Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.
Muls E; Rosseneu M; Bury J; Stul M; Lamberigts G; De Moor P
J Clin Endocrinol Metab; 1985 Nov; 61(5):882-9. PubMed ID: 3930554
[TBL] [Abstract][Full Text] [Related]
14. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
15. Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux.
Guerin M; Le Goff W; Frisdal E; Schneider S; Milosavljevic D; Bruckert E; Chapman MJ
J Clin Endocrinol Metab; 2003 Aug; 88(8):3738-46. PubMed ID: 12915663
[TBL] [Abstract][Full Text] [Related]
16. Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools.
Liang HQ; Rye KA; Barter PJ
Biochim Biophys Acta; 1995 Jun; 1257(1):31-7. PubMed ID: 7599178
[TBL] [Abstract][Full Text] [Related]
17. Characterization of lipoproteins containing a truncated form of apolipoprotein B, apolipoprotein B32.
McCormick SP; Day WA; George PM
Biochim Biophys Acta; 1995 Aug; 1258(1):49-56. PubMed ID: 7654780
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A-II, HDL metabolism and atherosclerosis.
Tailleux A; Duriez P; Fruchart JC; Clavey V
Atherosclerosis; 2002 Sep; 164(1):1-13. PubMed ID: 12119188
[TBL] [Abstract][Full Text] [Related]
19. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice.
Hayek T; Azrolan N; Verdery RB; Walsh A; Chajek-Shaul T; Agellon LB; Tall AR; Breslow JL
J Clin Invest; 1993 Sep; 92(3):1143-52. PubMed ID: 8376576
[TBL] [Abstract][Full Text] [Related]
20. Contrasting in vivo effects of murine and human apolipoprotein A-II. Role of monomer versus dimer.
Gong EL; Stoltfus LJ; Brion CM; Murugesh D; Rubin EM
J Biol Chem; 1996 Mar; 271(11):5984-7. PubMed ID: 8626380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
